Dr. Lisa Rimsza, in collaboration with Dr. Mike McGrath at the University of California, San Francisco, is the recipient of a 5-year $1,750,000 UM1 grant for her research lab to be the “Southwest Regional Biorepository” for the AIDS Cancer Specimen Resource Network.
The Arizona Lymphoma Repository (ALR) located at the University of Arizona Medical Center, Tucson, Arizona, has been in existence since 1983. The ALR has systematically acquired, annotated, and distributed tissues and data from patients with excess diagnostic tissue with benign or malignant lymphoid conditions including HIV(+) and HIV(-) malignancies. The ARL began actively consenting patients in 2004 in order to comply with human subjects’ research concerns and to allow more flexibility in sample use. The ALR became an affiliated site with the AIDS Cancer Specimen Resource Network (ACSR) in 2009, serving as a tissue resource and distributing materials to approved investigators. The ALR has also served as a Pathology core for the Southwest Oncology Group, a SPORE in lymphoma, and a large gene expression profiling consortium known as the Lymphoma & Leukemia Molecular Profiling Project. Therefore, this facility has extensive experience with tissue banking and provision of Pathology and technical services including a full range of histologic, immunohistochemical, tissue culture, and molecular capabilities. The ALR is now funded to be both one of 4 regional biorepositories as well as the Science and Technology Core for the ACSR. For more on the ACSR see their website at http://acsr.ucsf.edu/ .
From the ACSR website: “The AIDS and Cancer Specimen Resource (ACSR) is a resource for investigators working in the fields of HIV/AIDS, cancer, virology, immunology, pathology, epidemiology, tumor biology assay development, and many others. It is a biorepository for HIV-infected human biospecimens from a wide spectrum of HIV-related or associated diseases, including cancer, and from appropriate HIV-negative controls. The ACSR was established by the National Cancer Institute (NCI) in 1994 to acquire, store, and equitably distribute tumor tissues, biological fluids, and associated clinical information from patients with HIV-associated malignancies to the scientific research community-at-large."
Ruth Heaton 626-8415